Claire Shannon-Lowe

Colleges, School and Institutes

Immunology and Immunotherapy

Willingness to take PhD students

Yes

PhD projects

Dr Shannon-Lowe is interested in supervising doctoral research in the following areas:

The role of EBV in T and NK cell maliganacies.
The role of EBV in gastric carcinoma

View graph of relations

Most downloaded publications

Unexpected patterns of Epstein-Barr virus transcription revealed by a High throughput PCR array for absolute quantification of viral mRNA

Rosemary Tierney, Claire Shannon-Lowe, Leah Fitzsimmons, Andrew Bell & Martin Rowe, 1 Jan 2015, In : Virology. 474, 1, p. 117-30 14 p.

Research output: Contribution to journal › Article

158 downloads

Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2 : implications for stromal effects on virus-host interactions

Martin Rowe, Raithatha, S. & Claire Shannon-Lowe, Oct 2014, In : Journal of virology. 88, 20, p. 12065-12076

Research output: Contribution to journal › Article

132 downloads

Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle

Laura Quinn, Jianmin Zuo, Rachel Abbott, Claire Shannon-Lowe, Rosemary Tierney, Andrew Hislop & Martin Rowe, 21 Aug 2014, In : PLoS pathogens. 10, 8, e1004322.

Research output: Contribution to journal › Article

102 downloads

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination

Jill Brooks, Heather Long, Rosemary Tierney, Claire Shannon-Lowe, Leese, A., Fitzpatrick, M., Graham Taylor & Alan Rickinson, 20 Apr 2016, In : PLoS pathogens. 12, 4, p. 1 25 p., e1005549.

Research output: Contribution to journal › Article

90 downloads

The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation.

Jianmin Zuo, Currin, A., Griffin, BD., Claire Shannon-Lowe, Thomas, W., Ressing, ME., Wiertz, EJ. & Martin Rowe, 1 Jan 2009, In : PLoS pathogens. 5, 1, p. e1000255

Research output: Contribution to journal › Article

76 downloads

Recent publications

EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

Leah Fitzsimmons, Cartlidge, R., Chang, C., Sejic, N., Galbraith, L. C. A., Suraweera, C. D., Croom-Carter, D., Dewson, G., Rosemary Tierney, Andrew Bell, Claire Shannon-Lowe, Herold, M., Alan Rickinson, Colman, P. M., Huang, D. C. S., Strasser, A., Kvansakul, M., Martin Rowe & Kelly, G. L., 23 Oct 2019, In : Cell Death & Differentiation .

Research output: Contribution to journal › Article

MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers